Search Results

There are 17863 results for: content related to: Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Version of Record online : 23 FEB 2012, DOI: 10.1002/pds.3219

  3. Drug-induced Stevens–Johnson syndrome: case series from tertiary care centre in Gujarat

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 384–395, Damodar Bang, Tapan Shah, Divyesh Thakker, Yogesh Shah and Amit D. Raval

    Version of Record online : 28 FEB 2012, DOI: 10.1002/pds.3212

  4. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Version of Record online : 21 NOV 2012, DOI: 10.1002/pds.3377

  5. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pds.3234

  6. You have free access to this content
    When to randomize, or ‘Evidence-based medicine needs Medicine-based evidence’

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S2, May 2012, Pages: 6–12, John Concato

    Version of Record online : 3 MAY 2012, DOI: 10.1002/pds.3245

  7. Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 524–534, Sengwee Toh, Lingling Li, Leslie R. Harrold, Elizabeth A. Bayliss, Jeffrey R. Curtis, Liyan Liu, Lang Chen, Carlos G. Grijalva and Lisa J. Herrinton

    Version of Record online : 13 MAR 2012, DOI: 10.1002/pds.3238

  8. Use of systemic antifungals in daily clinical practice in the haematology and oncology setting: results of a prospective observational analysis

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 953–963, Barbara Metzke, Werner Christian Neubauer, Stefanie Hieke, Manfred Jung, Ralph Wäsch and Monika Engelhardt

    Version of Record online : 28 MAY 2012, DOI: 10.1002/pds.3278

  9. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  10. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Version of Record online : 24 JUN 2015, DOI: 10.1002/pds.3820

  11. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 489–497, Supinya Dechanont, Sirada Maphanta, Bodin Butthum and Chuenjid Kongkaew

    Version of Record online : 10 MAR 2014, DOI: 10.1002/pds.3592

  12. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Version of Record online : 24 FEB 2014, DOI: 10.1002/pds.3596

  13. Use of multiple sources and capture–recapture method to estimate the frequency of hospitalizations related to drug abuse

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 7, July 2012, Pages: 733–741, Emilie Jouanjus, Laure Pourcel, Sylvie Saivin, Laurent Molinier and Maryse Lapeyre-Mestre

    Version of Record online : 2 MAY 2012, DOI: 10.1002/pds.3280

  14. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 835–843, Hilda J. I. de Jong, Rob J. Vandebriel, Siti R. F. Saldi, Liset van Dijk, Henk van Loveren, Jan Willem Cohen Tervaert and Olaf H. Klungel

    Version of Record online : 6 JUN 2012, DOI: 10.1002/pds.3291

  15. Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 980–988, Chi-Shin Wu, Wen-Yi Shau, Hung-Yu Chan, Yen-Chieh Lee, Yun-Ju Lai and Mei-Shu Lai

    Version of Record online : 17 APR 2012, DOI: 10.1002/pds.3255

  16. Outpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 972–979, Falk Hoffmann, Gerd Glaeske, Franz Petermann and Christian J. Bachmann

    Version of Record online : 28 MAY 2012, DOI: 10.1002/pds.3295

  17. High use of tramadol in Germany: an analysis of statutory health insurance data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 9, September 2012, Pages: 1013–1021, Kathrin Tholen and Falk Hoffmann

    Version of Record online : 5 JUN 2012, DOI: 10.1002/pds.3266

  18. You have free access to this content
    Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S2, May 2012, Pages: 13–20, Sengwee Toh, Luis A. García Rodríguez and Miguel A. Hernán

    Version of Record online : 3 MAY 2012, DOI: 10.1002/pds.3248

  19. Trends in antihypertensives use among Moroccan patients

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1067–1073, G. Berrada El Azizi, S. Ahid, I. Ghanname, A. Belaiche, M. Hassar and Y. Cherrah

    Version of Record online : 14 MAY 2012, DOI: 10.1002/pds.3288

  20. You have full text access to this OnlineOpen article
    Near real-time vaccine safety surveillance using electronic health records—a systematic review of the application of statistical methods

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 225–237, Andreia Leite, Nick J. Andrews and Sara L. Thomas

    Version of Record online : 28 JAN 2016, DOI: 10.1002/pds.3966